alfuzosin and finasteride

alfuzosin has been researched along with finasteride in 19 studies

Research

Studies (19)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (15.79)	18.2507
2000's	11 (57.89)	29.6817
2010's	5 (26.32)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ballard, S; Blagg, J; Fox, D; Kenny, B	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Portet-Brunet, L	1
Colloi, D; Debruyne, FM; Delauche-Cavallier, MC; Geffriaud-Ricouard, C; Jardin, A; McCarthy, C; Resel, L; Witjes, WP	1
Clifford, GM; Farmer, RD	1
De la Rosette, JJ; Farmer, RD; Herings, RM; Leufkens, HG; Man in 't Veld, AJ; Souverein, PC	1
Clementi, G; Costantino, G; Matera, M	1
Dutkiewics, S	1
Doherty, AP	1
Larson, TR	1
Lee, M	1
Romics, I	1
Brown, GA; Sussman, DO	1
O'Leary, MP	1
Adomat, H; Elterman, DS; Fleshner, N; Guns, E; Hersey, K; Lawrentschuk, N; Wood, CA	1
Lee, HJ; Lee, JW	1
Kujala, PM; Murtola, TJ; Tammela, TL	1
Adamo, EB; Altavilla, D; Crea, G; Irrera, N; Lorenzini, C; Marini, H; Micali, A; Minutoli, L; Pisani, A; Puzzolo, D; Rinaldi, M; Squadrito, F; Valenti, A	1

Reviews

8 review(s) available for alfuzosin and finasteride

Article	Year
Pharmacological options in the treatment of benign prostatic hyperplasia. Journal of medicinal chemistry, 1997, Apr-25, Volume: 40, Issue:9 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship	1997
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Medical therapy for benign prostatic hyperplasia: a review of the literature. European urology, 2000, Volume: 38, Issue:1 Topics: Adrenergic alpha-Antagonists; Doxazosin; Finasteride; Humans; Indoramin; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	2000
Current treatment options for benign prostatic hyperplasia and their impact on sexual function. Urology, 2003, Volume: 61, Issue:4 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Erectile Dysfunction; Finasteride; Humans; Laser Coagulation; Male; Middle Aged; Minimally Invasive Surgical Procedures; Prostatectomy; Prostatic Hyperplasia; Quality of Life; Quinazolines; Sexual Behavior; Transurethral Resection of Prostate	2003
Alfuzosin hydrochloride for the treatment of benign prostatic hyperplasia. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2003, Jul-15, Volume: 60, Issue:14 Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Delayed-Action Preparations; Drug Interactions; Drug Therapy, Combination; Finasteride; Humans; Male; Prostatic Hyperplasia; Quality of Life; Quinazolines	2003
[Pharmacologic treatment of benign prostatic hyperplasia]. Orvosi hetilap, 2003, Sep-14, Volume: 144, Issue:37 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Doxazosin; Enzyme Inhibitors; Finasteride; Humans; Male; Phytotherapy; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	2003
Treatment and pharmacologic management of BPH in the context of common comorbidities. The American journal of managed care, 2006, Volume: 12, Issue:5 Suppl Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Azasteroids; Cardiovascular Diseases; Comorbidity; Doxazosin; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Global Health; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome	2006
Apoptotic Pathways Linked to Endocrine System as Potential Therapeutic Targets for Benign Prostatic Hyperplasia. International journal of molecular sciences, 2016, Aug-11, Volume: 17, Issue:8 Topics: Apoptosis; Dutasteride; Endocrine System; Finasteride; Humans; Male; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Urological Agents	2016

Trials

2 trial(s) available for alfuzosin and finasteride

Article	Year
Sustained-release alfuzosin, finasteride and the combination of both in the treatment of benign prostatic hyperplasia. European ALFIN Study Group. European urology, 1998, Volume: 34, Issue:3 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines	1998
[Long-term therapy of benign prostatic hyperplasia. Our experience]. Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 2001, Volume: 53, Issue:1 Topics: Adrenergic alpha-Antagonists; Aged; Doxazosin; Finasteride; Follow-Up Studies; Humans; Male; Mepartricin; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Quinazolines; Time Factors	2001

Article

Year

Sustained-release alfuzosin, finasteride and the combination of both in the treatment of benign prostatic hyperplasia. European ALFIN Study Group.

European urology, 1998, Volume: 34, Issue:3

Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines

1998

[Long-term therapy of benign prostatic hyperplasia. Our experience].

Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 2001, Volume: 53, Issue:1

Topics: Adrenergic alpha-Antagonists; Aged; Doxazosin; Finasteride; Follow-Up Studies; Humans; Male; Mepartricin; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Quinazolines; Time Factors

2001

Other Studies

9 other study(ies) available for alfuzosin and finasteride

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
[Drugs for prostatic adenoma]. Soins; la revue de reference infirmiere, 1995, Issue:599 Topics: Adrenergic alpha-Antagonists; Drug Monitoring; Enzyme Inhibitors; Finasteride; Humans; Male; Prostatic Hyperplasia; Quinazolines	1995
Evaluating adverse cardiovascular effects of drug treatment for benign prostatic hyperplasia (BPH): methodological considerations. Journal of clinical epidemiology, 2001, Volume: 54, Issue:5 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Adult; Aged; Bias; Cardiovascular Diseases; Case-Control Studies; Finasteride; Humans; Male; Middle Aged; Morbidity; Netherlands; Prazosin; Prognosis; Prostatic Hyperplasia; Quinazolines; Research Design; Risk Factors; Sulfonamides; Tamsulosin	2001
Efficacy and tolerability of drugs for treatment of benign prostatic hyperplasia. International urology and nephrology, 2001, Volume: 32, Issue:3 Topics: Adrenergic alpha-Antagonists; Aged; Doxazosin; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Phytotherapy; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	2001
Benign prostatic hyperplasia. Hospital medicine (London, England : 1998), 2003, Volume: 64, Issue:2 Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Doxazosin; Drug Therapy, Combination; Enzyme Inhibitors; Finasteride; Humans; Male; Prostatic Hyperplasia; Quinazolines	2003
A current review of medical therapy for benign prostatic hyperplasia. The Journal of the American Osteopathic Association, 2004, Volume: 104, Issue:2 Suppl 2 Topics: Adrenergic alpha-Antagonists; Algorithms; Azasteroids; Cholestenone 5 alpha-Reductase; Doxazosin; Drug Therapy, Combination; Dutasteride; Finasteride; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Urination Disorders	2004
Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors. The Journal of urology, 2010, Volume: 183, Issue:5 Topics: Administration, Oral; Adrenergic alpha-Antagonists; Azasteroids; Capsules; Cholestenone 5 alpha-Reductase; Chromatography, High Pressure Liquid; Doxazosin; Drug Contamination; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Phytotherapy; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tablets; Tamsulosin	2010
Reversible visual loss caused by combination therapy of alfuzosin and finasteride in a patient with uveitic glaucoma. Cutaneous and ocular toxicology, 2013, Volume: 32, Issue:2 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Antihypertensive Agents; Drug Therapy, Combination; Finasteride; Glaucoma; Humans; Male; Middle Aged; Optic Neuropathy, Ischemic; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Vision Disorders	2013
High-grade prostate cancer and biochemical recurrence after radical prostatectomy among men using 5α-reductase inhibitors and alpha-blockers. The Prostate, 2013, Volume: 73, Issue:9 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Azasteroids; Cohort Studies; Disease-Free Survival; Dutasteride; Finasteride; Finland; Humans; Kallikreins; Male; Neoplasm Grading; Neoplasm Recurrence, Local; Proportional Hazards Models; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Quinazolines; Sulfonamides; Survival Rate; Tamsulosin	2013